Reprint

Cavitation-Enhanced Drug Delivery and Immunotherapy

Edited by
November 2023
260 pages
  • ISBN978-3-0365-9434-7 (Hardback)
  • ISBN978-3-0365-9435-4 (PDF)

This book is a reprint of the Special Issue Cavitation-Enhanced Drug Delivery and Immunotherapy that was published in

Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary

Cavitation-Enhanced Drug Delivery and Immunotherapy is a rapidly evolving area that has been buoyed in recent years by the development of methods harnessing the activity of ultrasound-stimulated bubbles, known as cavitation. When properly controlled, cavitation can help overcome physical barriers to drug delivery whilst providing readily measurable information for timely quantitative feedback and treatment guidance. Microbubble-assisted therapies have demonstrated impressive advancements in clinical trials and pre-clinical areas, including applications in neurology, oncology, cardiology and beyond.

Format
  • Hardback
License
© by the authors
Keywords
passive cavitation detection; size-isolated microbubbles; focused ultrasound; stable cavitation; inertial cavitation; perfluoropentane microdroplets; cavitation; microfluidic emulsion manufacturing; polydispersity; ultrasound contrast agent; ultrasound duty cycle; intravascular ultrasound; ultrasound; targeted drug delivery; microbubble; cavitation; sonoporation; nanoparticle; gene therapy; miRNA delivery; microRNA-126; microbubbles; sonoporation; passive cavitation detection; ultrasound; endothelial cells; HUVEC; therapeutic angiogenesis; sonoporation; round window membrane; metabolomics; perilymph; inner ear; SonoCloud; GL261 mouse model; ultrasound-mediated drug delivery; glioblastoma; immune checkpoint inhibitors; radiotherapy; tumor hypoxia; contrast-enhanced ultrasound; oxygen-loaded microbubbles; drug delivery; head and neck cancer; lonidamine; metformin; microbubble; cavitation nuclei; Biofilm; microbubble targeting; cationic microbubble; drug delivery; ultrasound drug delivery; pancreatic cancer; paclitaxel; gemcitabine; cetuximab; drug delivery; SonoTran Particles; sonoporation; passive acoustic mapping; large animal cancer model; focused ultrasound; targeted microbubbles; ultrasound imaging probes; ultrasound-targeted delivery; therapy; immunotherapy; ultrasound; ultrasound targeting; ultrasound drug delivery; sonoporation; microbubbles; acoustic droplet vaporization; ultrasound; cavitation; cancer; immunotherapy; checkpoint inhibitor; n/a